BASAL CELL CARCINOMA

This early study tested a new radiation patch (CivaDerm) for treating common skin cancers like basal cell and squamous cell carcinoma. Ten adults with small tumors on their trunk or limbs received the patch treatment. The goal was to see if the device could safely deliver targete…

This study looked at how well the drug cemiplimab works for people with advanced skin cancers (squamous cell or basal cell carcinoma) in real-world settings, not just in controlled trials. Researchers tracked 287 patients to measure tumor shrinkage, survival, side effects, and qu…

This study tested a drug called vismodegib in 104 people with advanced basal cell carcinoma, a type of skin cancer that had spread or could not be surgically removed. All participants took the drug daily until their cancer worsened, side effects became too severe, or they chose t…

This study tested giving a daily pill called sonidegib for 12 weeks before surgery or a cream for people with basal cell carcinoma in cosmetically sensitive areas like the face. The goal was to see if the pill could shrink tumors enough to make surgery less scarring or even avoid…

This study allowed people with certain cancers (ovarian, basal cell, or colorectal) who had already shown benefit from the drug vismodegib in earlier trials to keep receiving it. The main goal was to track safety and side effects over time. Only 19 patients took part, all of whom…

This early-phase study tested an experimental drug called cemiplimab, injected directly into skin tumors before surgery. The goal was to see if it is safe and how well it shrinks two types of skin cancer: squamous cell carcinoma and basal cell carcinoma. 97 adults with recurrent,…

This study tested the drug vismodegib in 55 people with advanced basal cell carcinoma (a type of skin cancer) to see if taking it before surgery could make the tumor smaller and allow for a less extensive operation. Participants took the drug for a period before their planned sur…

This study tested a special microscope that uses two-photon fluorescence to check if skin cancer is left behind during Mohs surgery. Researchers compared its results to the standard frozen section method in 135 people with basal cell carcinoma. The goal was to see how well the ne…

This study looked at the long-term safety of the drug sonidegib in 323 adults with a type of advanced skin cancer called locally advanced basal cell carcinoma. Researchers tracked side effects, serious reactions, and deaths during treatment. The goal was to collect real-world saf…

This study looked at whether telling people about their genetic risk for melanoma (a serious skin cancer) would make them more careful in the sun. Over 2,000 adults took part, and researchers tracked things like time in the sun, sunscreen use, and sunburns. The goal was to see if…